Designed specifically for bioreactor-scale workflows, the system reportedly requires less than 15 minutes of hands-on time.

A structurally tuned HPV cancer SNA vaccine boosts CD8⁺ T‑cell responses and slows tumor growth in mice and patient‑derived spheroids, a study shows.

It turns out we might be building up our brain when we exercise.” Betley is corresponding author of the researchers’ published paper in Neuron, titled “ Exercise-induced activation of ventromedial ...

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.

Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.

This eBook explores how innovation and shifting patient expectations are reshaping modern diagnostics—and advancing progress toward global STI elimination goals.

AI can help protein engineers optimize the transcription enzymes used to make mRNA-based vaccines and therapeutics, say the authors of a new study.

Michelle Lee, PhD, unpacks how physical AI that integrate scientific reasoning with the wet lab will accelerate biological discovery.

From SLAS in Boston, Julianna LeMieux and Uduak Thomas share highlights, key sessions, and takeaways on automation.

Designing a high-density fed-batch, E. coli-based strategy to produce recombinant GLP-1 cuts upstream production costs 20–30%.

Ion mobility adds a powerful new dimension to biopharma separations as complex therapeutics outgrow traditional LC–MS.